Octreotide in acute bleeding esophageal varices: A prospective randomized study

Hepato-Gastroenterology

Volumn 47, Issue 35, 2000, Pages 1310-1314

  Freitas, D S ^a   Sofia, C ^a   Pontes, J M ^a   Gregorio, C ^a   Cabral, J P ^a   Andrade, P ^a   Rosa, A ^a   Camacho, E ^a   Ferreira, M ^a   Portela, F ^a   Romaozinho, J M ^a   Tome, L ^a   Gouveia, H ^a   Leitao, M ^a   Pimenta, I ^a   Donato, A ^a  

^a CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

Author keywords

Bleeding esophageal varices; Endoscopic sclerotherapy; Octreotide

Indexed keywords

OCTREOTIDE;

ADULT; AGED; ARTICLE; BLOOD TRANSFUSION; CLINICAL TRIAL; COLLATERAL CIRCULATION; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; ESOPHAGUS VARICES BLEEDING; FEMALE; HEMOSTASIS; HUMAN; LIGATION; MAJOR CLINICAL STUDY; MALE; PORTAL VEIN; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SCLEROTHERAPY;

ACUTE DISEASE; EMERGENCIES; ESOPHAGEAL AND GASTRIC VARICES; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMANS; MALE; MIDDLE AGED; OCTREOTIDE; PROSPECTIVE STUDIES; SCLEROTHERAPY;

EID: 0033778166     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Drug therapy for variceal haemorrhage
2. Variceal injection sclerotherapy
3. Assessment of the risk of bleeding from esophageal varices by continuous monitoring of portal pressure
4. The pharmacotherapy of portal hypertension
5. Placebo-controlled trial of terlipressin (glypressin) in the management of acute variceal bleeding
6. Controlled trial of terlipressin (Glypressin) versus vasopressin in the early treatment of oesophageal varices
7. A randomized trial of vasopressin and vasopressin plus nitroglycerin in the control of acute variceal hemorrhage
8. Octreotide in variceal bleeding
9. The effects of a somatostatin analogue SMS 201-995 on hepatic haemodynamics in the cirrhotic rat
10. The effect of somatostatin and SMS 201-995 on hepatic and systemic haemodynamics in patients with cirrhosis and portal hypertension
11. Effects of a somatostatin analogue SMS 201-995 on hepatic haemodynamics in the pig and on intravariceal pressure in man
12. Haemodynamic effects of subcutaneous administration of SMS 201-995, a long acting somatostatin analogue, in patients with cirrhosis and portal hypertension
13. Octreotide in the treatment of disorders of the gastrointestinal tract
14. Octreotide compared with placebo in a treatment stategy for early rebleeding in cirrhosis. A double-blind, randomized pragmatic trial
15. Sandostatin therapy of acute oesophageal variceal bleeding
16. Octreotide infusion or emergency sclerotherapy for variceal haemorrhage
17. Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices
18. The management of variceal bleeding
19. Gastroesophageal varices: Pathogenesis and therapy of acute bleeding
20. Management of portal hypertension
21. Endoscopic techniques for the management of active variceal bleeding
22. Clinical pharmacology of active variceal bleeding
23. A randomized controlled trial comparingoctreotide and vasopressin in the control of acute esophageal variceal bleeding
24. A predictive model for very early rebleeding from varices
25. Terlipressin plus transderm nitroglycerin vs. octreotide in the control of acute bleeding from esophageal varices: A multicenter randomized trial
26. Vasopressine, somatostatine et hemorragies digestives de l'hypertension portale: Le bout du tunnel?
27. Sclerotherapy with or without octreotide for acute variceal bleeding
28. Octreotide infusion or emergency sclerotherapy for variceal haemorrage
29. Sclerotherapy plus octreotide versus sclerotherapy alone in the prevention of early rebleeding from esophageal varices: A randomized, double-blind, placebo-controlled, multicenter trial